The inaugural Saudi Conference on Gynaecology and Fertility (GFS) has concluded in Jeddah, spotlighting the Kingdom’s growing role in advanced women’s healthcare, fertility innovation, and medical technology.

Held from 29–31 January under the patronage of His Highness Prince Saud bin Abdullah bin Jalawi Al Saud, Governor of Jeddah, the event brought together more than 40 regional and international experts. The meeting was organised by Dr Ayman Oraif, Consultant and Director of the IVF Centre and Reproductive Surgery at King’s College Hospital London – Jeddah, and positioned as a milestone in Saudi Arabia’s healthcare transformation under Vision 2030.

Sessions focused on the future of fertility treatment, minimally invasive gynaecologic surgery, and advances in reproductive and oncologic procedures. A key theme was the integration of advanced technologies to improve outcomes and quality of care.

Much attention centred on Embryology 4.0 – a model combining clinical expertise with digital tools, including artificial intelligence (AI) for embryo selection and assessment, in vitro maturation techniques, and improved laboratory accreditation standards.

Dr Oraif highlighted the Kingdom’s readiness to adopt emerging reproductive technologies and pointed to regenerative medicine as a promising frontier. He discussed research into stem cell use for treating infertility and premature ovarian insufficiency, a condition affecting around 1% of women under 40.

Organisers say the conference is expected to strengthen research collaboration and reinforce Saudi Arabia’s position as a regional hub for medical innovation in women’s health and fertility care.

The IH&H team recently spoke to healthcare industry experts about what is required for successful medical case management in the Middle East.